UBS Group
OCS icon

UBS Group’s Oculis Holding OCS Stock Holding History

UBS Group’s Portfolio OCS Stock Details OCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.67M Buy
62,746
+16,830
+37% +$446K ﹤0.01% 5128
2025
Q4 		$917K Sell
45,916
-28,816
-39% -$576K ﹤0.01% 5653
2025
Q3 		$1.31M Sell
74,732
-51,783
-41% -$918K ﹤0.01% 5327
2025
Q2 		$2.46M Buy
126,515
+13,550
+12% +$249K ﹤0.01% 4602
2025
Q1 		$2.15M Buy
112,965
+4,123
+4% +$84.5K ﹤0.01% 4643
2024
Q4 		$1.85M Buy
108,842
+91,065
+512% +$1.43M ﹤0.01% 4791
2024
Q3 		$218K Buy
17,777
+1,277
+8% +$15K ﹤0.01% 5808
2024
Q2 		$197K Buy
16,500
+15,403
+1,404% +$183K ﹤0.01% 5666
2024
Q1 		$13.2K Buy
+1,097
New +$13.1K ﹤0.01% 7113
2023
Q4 		– Sell
-2,002
Closed -$22K – 9733
2023
Q3 		$22K Buy
2,002
+2,000
+100,000% +$25.1K ﹤0.01% 6758
2023
Q2 		$25 Sell
2
-1,210
-100% -$13.5K ﹤0.01% 8669
2023
Q1 		$9.01K Buy
+1,212
New +$10.1K ﹤0.01% 7677

Other funds holding OCS

EFM
EQT Fund Management Luxembourg $1.02B AUM
GL
Gildi lifeyrissjodur Reykjavik $197M AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

UBS Group's OCS Position: Q1 2026 in Review

UBS Group increased its Oculis Holding (OCS) stake by 37% in Q1 2026, buying an estimated $446K and bringing the position to 62,746 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #5128.

UBS Group first reported a position in OCS in Q1 2023 and has held it in 12 quarters since. The position peaked at $2.46M in Q2 2025. 57 funds tracked by Wall St. Rank hold OCS as of Q1 2026.

  • UBS Group held 62,746 shares of Oculis Holding worth $1.67M as of Q1 2026.
  • UBS Group bought 16,830 Oculis Holding shares in Q1 2026, an estimated $446K.
  • Oculis Holding made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5128 holding.
  • UBS Group first reported a position in Oculis Holding in Q1 2023 and has held it in 12 quarters since.
  • UBS Group's Oculis Holding position peaked at $2.46M in Q2 2025.
  • 57 funds tracked by Wall St. Rank held Oculis Holding as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.